OncoMethylome Sciences' board of directors has named Jan Groen to serve as the company's chief executive officer.
With more than 25 years of experience in the clinical diagnostics industry, Groen was previously the president and chief operating officer of Agendia, responsible for the firm's US and European operations. He was also VP of research and development of Quest subsidiary Focus Diagnostics, and has held numerous management and scientific positions at ViroClinics, the Erasmus Medical Center, and Akzo-Nobel.